Synergy Investment Management LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the 4th quarter, HoldingsChannel reports. The fund bought 650 shares of the biotechnology company’s stock, valued at approximately $386,000.
Several other large investors have also recently added to or reduced their stakes in the business. Prestige Wealth Management Group LLC raised its stake in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise during the 4th quarter valued at about $40,000. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise during the 3rd quarter worth about $41,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp boosted its holdings in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several brokerages recently commented on AXON. Needham & Company LLC reissued a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Barclays set a $726.00 target price on Axon Enterprise and gave the company an “overweight” rating in a research note on Thursday. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a research report on Thursday, February 20th. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $587.38.
Insiders Place Their Bets
In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of the stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares in the company, valued at $116,852,877.56. This represents a 0.70 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 6,407 shares of company stock worth $4,122,925. Corporate insiders own 6.10% of the company’s stock.
Axon Enterprise Stock Performance
Axon Enterprise stock opened at $525.75 on Tuesday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The firm’s 50 day simple moving average is $607.58 and its 200-day simple moving average is $526.43. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $40.09 billion, a P/E ratio of 135.85, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
- Five stocks we like better than Axon Enterprise
- High Flyers: 3 Natural Gas Stocks for March 2022
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What to Know About Investing in Penny Stocks
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.